Does EVOLOCUMAB Cause Low density lipoprotein increased? 1,024 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,024 reports of Low density lipoprotein increased have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.7% of all adverse event reports for EVOLOCUMAB.
1,024
Reports of Low density lipoprotein increased with EVOLOCUMAB
0.7%
of all EVOLOCUMAB reports
3
Deaths
36
Hospitalizations
How Dangerous Is Low density lipoprotein increased From EVOLOCUMAB?
Of the 1,024 reports, 3 (0.3%) resulted in death, 36 (3.5%) required hospitalization, and 5 (0.5%) were considered life-threatening.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 1,024 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Low density lipoprotein increased?
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
LORLATINIB (78)
Which EVOLOCUMAB Alternatives Have Lower Low density lipoprotein increased Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE